Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-07-16FDA Approved: CLONIDINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic clonidine product from Mylan Pharmaceuticals via an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) [Phase 1]
A Phase 1 trial assessed the bioequivalence of a losartan-HCTZ combination tablet versus coadministration of its components for hypertension…
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients [Phase 3]
This Phase 3 clinical trial reports on the effect of telmisartan on inflammatory parameters in hypertensive patients, including those with m…
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317) [Phase 1]
Phase 1 trial updating the effects of losartan alone and with isosorbide mononitrate on central blood pressure measurements in hypertension.
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of the candesartan cilexetil plus hydrochlorothiazide combination in adults…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: Clinical Investigation on the Effects of a Vegetable Juice Treatment [Phase 1]
A Phase 1 clinical trial evaluating the effects of a vegetable juice treatment on cardiovascular disease and blood pressure has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED) [Phase 1]
This Phase 1 study evaluated methodologies for measuring swelling of the leg and ankle and was sponsored by Merck; the trial has completed a…
-
CLINICAL_TRIALS research · 2010-07-08Clinical Trial Update: Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
This clinical trial update reports completion of the Dallas Heart Study 2 return clinic visit for the Dallas Heart Study cohort.
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness [NA]
This clinical trial update reports results from a rehabilitation in primary care project aimed at improving health status in adults with chr…
-
FDA approval · 2010-07-06FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for atenolol submitted by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients. [Phase 2]
Phase 2 efficacy study evaluating a pioglitazone and ramipril combination in non-diabetic hypertensive patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED) [Phase 3]
A Phase 3 safety study comparing Phenylephrine HCl Extended Release 30 mg tablets to placebo has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics [Phase 4]
Phase 4 trial evaluating the safety and efficacy of triple therapy with olmesartan, amlodipine, and hydrochlorothiazide in patients with Typ…
-
FDA approval · 2010-07-02FDA Approved: SPIRONOLACTONE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for generic spironolactone, establishing a bioequivalent product to the refer…
-
FDA approval · 2010-06-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amlodipine besylate by Aurobindo Pharma Limited as a generic product.
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: SPHERE Hypertension Intervention Study [NA]
A clinical trial update indicates that the SPHERE Hypertension Intervention Study sponsored by the University of Washington has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-25Clinical Trial Update: Felodipine Event Reduction Study [NA]
This update notes the completion of a clinical trial evaluating felodipine for event reduction in patients with hypertension.
-
FDA approval · 2010-06-23FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc. under ANDA070976.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension [Phase 2]
Phase 2 trial assessing the efficacy and safety of azilsartan in adults with essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: The Effect of Berry Consumption on Indicators of Cardiovascular Disease Risk [NA]
A completed clinical trial evaluated whether berry consumption influences indicators of cardiovascular disease risk, including blood pressur…
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: I Am Able: Population Based Rehabilitation in a Family Health Team [NA]
A completed clinical trial update for a population-based rehabilitation program (I Am Able) in a family health team, assessing management of…
-
FDA approval · 2010-06-15FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for doxazosin mesylate filed by Teva Pharmaceuticals USA, Inc. under ANDA075536.
-
FDA approval · 2010-06-04FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic fixed-dose combination of metoprolol tartrate and hydrochlorothiazide, manufactured …
-
FDA approval · 2010-06-04FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application from Dr. Reddy's Laboratories Limited for a fixed-dose combination tablet of amlodipine besylate and…
-
CLINICAL_TRIALS research · 2010-06-03Clinical Trial Update: Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) [Phase 4]
A Phase 4 clinical trial update for the Kagoshima Collaborate Trial in Metabolic Syndrome (KACT) sponsored by Kagoshima University. The tria…